Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ovation Science Inc.

Market Cap 6L 4L 4L 3L 3L 3.94Cr 6L 39.26L 15.2L 1.9Cr 15.44L 15.11L 6.6Cr P/E Ratio 2024
-2.68x
P/E Ratio 2025 -2.26x
Enterprise Value 8L 6L 5L 4L 4L 5.38Cr 8L 53.62L 20.76L 2.59Cr 21.09L 20.64L 9.02Cr EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day-53.95%
3 months+65.09%
6 months+18.64%
Current year+18.64%
Current year 0.02
Extreme 0.0212
0.08
1 year 0.01
Extreme 0.0136
0.08
3 years 0
Extreme 0.0025
0.12
5 years 0
Extreme 0.0023
0.16
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-53.95%-.--% - - 4L
-0.20%+3.34%+1.32%-4.70% 24TCr
+1.14%+5.91%+48.11% - 4.9TCr
0.00%+1.36%+201.84% - 1.01TCr
+1.42%+0.74%+5.22%-61.20% 629.79Cr
0.00%+0.54%-19.97%+4.29% 454.06Cr
-2.28%-4.63%-25.57%-41.81% 375.6Cr
+4.40%+17.96%-51.27%-41.94% 345.47Cr
+1.82%+12.68%-28.87%-25.18% 315.01Cr
-0.75%+3.37%-24.21%-50.02% 256.84Cr
Average -4.86%+4.89%+11.85%-31.51% 3.55TCr
Weighted average by Cap. +0.08%+3.38%+13.22%-7.63%

Financials

2024 2025
Net sales 1L 80.84T 70.16T 64.67T 60.59T 77.41L 1L 8L 3L 37.31L 3L 3L 1.3Cr 67.89T 48.48T 42.07T 38.78T 36.33T 46.42L 69.3T 5L 2L 22.37L 2L 2L 77.79L
Net income -5L -3L -3L -3L -2L -3.12Cr -5L -31.08L -12.03L -1.5Cr -12.23L -11.97L -5.23Cr -6L -5L -4L -4L -3L -4.32Cr -6L -43.01L -16.65L -2.08Cr -16.92L -16.56L -7.23Cr
Net Debt 3L 2L 2L 2L 1L 1.81Cr 3L 18.07L 7L 87.39L 7L 7L 3.04Cr 2L 2L 1L 1L 1L 1.44Cr 2L 14.36L 6L 69.47L 6L 6L 2.42Cr
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!